CoChat

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by circulating autoantibodies and the formation of immune complexes. In these responses, the selecting self-antigens likely derive from the remains of dead and dying cells, as well as from disturbances in clearance. During cell death/activation, microparticles (MPs) can be released to the circulation. Previous MP studies in SLE have been limited in size and differ regarding numbers and phenotypes. Therefore, to characterize MPs more completely, we investigated 280 SLE patients and 280 individually matched controls. MPs were measured with flow cytometry and phenotyped according to phosphatidylserine expression (PS+/PS−), cellular origin and inflammatory markers. MPs, regardless of phenotype, are 2–10 times more abundant in SLE blood compared to controls. PS− MPs predominated in SLE, but not in controls (66% vs. 42%). Selectively in SLE, PS− MPs were more numerous in females and smokers. MP numbers decreased with declining renal function, but no clear association with disease activity was observed. The striking abundance of MPs, especially PS− MPs, suggests a generalized disturbance in SLE. MPs may be regarded as “liquid biopsies” to assess the production and clearance of dead, dying and activated cells, i.e. pivotal events for SLE pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep36025

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Distribution of phosphatidylserine negative and phosphatidylserine positive microparticles in SLE patients. Microparticles in SLE plasma (n = 280) were detected by flow cytometry and defined as particles less than 1.0 μm in size and either positive or negative for lactadherin-FITC. Each subpopulation was then phenotyped according to origin or expression of inflammation/activation markers. Dark grey = phosphatidylserine positive (PS+) microparticles; light grey = phosphatidylserine negative (PS−) microparticles; PMPs = platelet microparticles; EMPs = endothelial microparticles; LMPs = leukocyte microparticles; MMPs = monocyte microparticles; CD40L = Cd40 ligand; TF = tissue factor; VCAM-1 = Vascular cell adhesion protein 1; HMGB1 = High mobility group box 1. Each group (PS+ vs. PS−) was compared with t-test after log transformation of data. Bars represent median values and line indicates interquartile range (25th and 75th percentile). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Figure 1 Distribution of phosphatidylserine negative and phosphatidylserine positive microparticles in SLE patients. Microparticles in SLE plasma (n = 280) were detected by flow cytometry and defined as particles less than 1.0 μm in size and either positive or negative for lactadherin-FITC. Each subpopulation was then phenotyped according to origin or expression of inflammation/activation markers. Dark grey = phosphatidylserine positive (PS+) microparticles; light grey = phosphatidylserine negative (PS−) microparticles; PMPs = platelet microparticles; EMPs = endothelial microparticles; LMPs = leukocyte microparticles; MMPs = monocyte microparticles; CD40L = Cd40 ligand; TF = tissue factor; VCAM-1 = Vascular cell adhesion protein 1; HMGB1 = High mobility group box 1. Each group (PS+ vs. PS−) was compared with t-test after log transformation of data. Bars represent median values and line indicates interquartile range (25th and 75th percentile). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.CC BY · PubMed Central
Figure 2 Number and phenotype of lactadherin positive (A) or lactadherin negative (B) microparticles in SLE patients and matched controls. Microparticles in SLE (n = 280) and matching controls (n = 280) were detected by flow cytometry and defined as particles less than 1.0 μm in size and either positive for lactadherin (A) or negative for lactadherin (B). Each subpopulation was then phenotyped according to origin or expression of inflammation/activation markers. Dark grey = SLE patients; light grey = matching controls; PMPs = platelet microparticles; EMPs = endothelial microparticles; LMPs = leukocyte microparticles; MMPs = monocyte microparticles; CD40L = Cd40 ligand; TF = tissue factor; VCAM-1 = Vascular cell adhesion protein 1; HMGB1 = High mobility group box 1. Each group (patients vs. controls) was compared with t-test after log transformation of data. Bars represent median values and Platelet microparticles and endothelial microparticles expressing complement *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Figure 2 Number and phenotype of lactadherin positive (A) or lactadherin negative (B) microparticles in SLE patients and matched controls. Microparticles in SLE (n = 280) and matching controls (n = 280) were detected by flow cytometry and defined as particles less than 1.0 μm in size and either positive for lactadherin (A) or negative for lactadherin (B). Each subpopulation was then phenotyped according to origin or expression of inflammation/activation markers. Dark grey = SLE patients; light grey = matching controls; PMPs = platelet microparticles; EMPs = endothelial microparticles; LMPs = leukocyte microparticles; MMPs = monocyte microparticles; CD40L = Cd40 ligand; TF = tissue factor; VCAM-1 = Vascular cell adhesion protein 1; HMGB1 = High mobility group box 1. Each group (patients vs. controls) was compared with t-test after log transformation of data. Bars represent median values and Platelet microparticles and endothelial microparticles expressing complement *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.CC BY · PubMed Central
Figure 3 Platelet microparticles and endothelial microparticles expressing complement factor 4d in SLE patients and matched controls. Microparticles in SLE and matching controls were detected by flow cytometry and defined as particles less than 1.0 μm in size and positive for either CD41 (platelet origin) or CD144 (endothelial origin). Later, the expression of complement factor 4d was measured in each subpopulation. PMPs = platelet microparticles; EMPs = endothelial microparticles; C4d = complement factor 4d. Each group (patients vs. controls) was compared with t-test after log transformation of data. Bars represent median values and line indicates interquartile range (25th and 75th percentile). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Figure 3 Platelet microparticles and endothelial microparticles expressing complement factor 4d in SLE patients and matched controls. Microparticles in SLE and matching controls were detected by flow cytometry and defined as particles less than 1.0 μm in size and positive for either CD41 (platelet origin) or CD144 (endothelial origin). Later, the expression of complement factor 4d was measured in each subpopulation. PMPs = platelet microparticles; EMPs = endothelial microparticles; C4d = complement factor 4d. Each group (patients vs. controls) was compared with t-test after log transformation of data. Bars represent median values and line indicates interquartile range (25th and 75th percentile). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 85

Metadata

Authors
Mobarrez, F., Vikerfors, A., Gustafsson, J. T., Gunnarsson, I., Zickert, A., Larsson, A., Pisetsky, D. S., Wallén, H., & Svenungsson, E.
Affiliations
  • Karolinska University Hospital (SE)
  • Uppsala University Hospital (SE)
  • Duke Medical Center (US)
  • Danderyds sjukhus (SE)
Corresponding author
Mobarrez, Fariborz
Venue
Scientific Reports
Published
2016-10-25
Volume
6
Issue
1
Pages
36025-36025
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2534182712
Cited by
85
References
56
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 8 · 2017: 5
FWCI
9.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
Funders
  • Hjärt-Lungfonden
  • Karolinska Institutet
  • Stockholms Läns Landsting
  • Vetenskapsrådet
  • Svenska Läkaresällskapet
  • Reumatikerförbundet
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
systemic lupus erythematosus, microparticles, phosphatidylserine, cell death, immune complexes, autoantibodies, liquid biopsy, renal function, disease activity, smoking, sex differences
MeSH terms
Antigen-Antibody Complex, Autoantibodies, Autoantigens, Blood Platelets, Cross-Sectional Studies, Female, Flow Cytometry, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Thromboplastin, Biomarkers, Vascular Cell Adhesion Molecule-1, CD40 Ligand, HMGB1 Protein, Cell-Derived Microparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.